Tech Company Financing Transactions
ViAqua Therapeutics Funding Round
On 9/5/2023, ViAqua Therapeutics raised $8.3 million in investment from S2G Ventures, Agriline and Circle Investment.
Transaction Overview
Company Name
Announced On
9/5/2023
Transaction Type
Venture Equity
Amount
$8,250,000
Round
Undisclosed
Investors
Proceeds Purpose
Funding will enable ViAqua to bring its first product to market, invest in R&D for future products, and prove the platform's ability to deliver RNA-based solutions at scale.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Gutwirth Park
Technion City, 3200003
IL
Technion City, 3200003
IL
Phone
Undisclosed
Website
Email Address
Overview
ViAqua Therapeutics was established in September 2014 to address the growing need for effective, affordable health management of diseases in aquaculture. To date, ViAqua has received investments from The Trendlines Group, Nutreco, VisVires New Protein, S2G Ventures, Thai Union, and the Technion--Israel Institute of Technology, with support from the Israel Innovation Authority.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shai Ufaz
Co-Founder
Shai Einbinder
Browse more venture capital transactions:
Prev: 9/5/2023: Star Therapeutics venture capital transaction
Next: 9/5/2023: Orange Quantum Systems venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs